It's things like this ...

As you all know the company I work for, Onyx Pharmaceuticals, is a pharmceutical company involved in clinical trials for cancer drugs.
Well, we received some very good news today. Nexavar (the drug) met its goal in breast cancer study. This is very exciting for the patients (not to mention my stock portfolio). Nexavar is already approved in liver and kidney cancer. Let's keep our fingers crossed that it continues to help breast cancer patients, too.